Your session is about to expire
← Back to Search
Decision Making Support for Parkinson's Disease
N/A
Recruiting
Led By Jiayun Xu
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-report a clinical diagnosis of Parkinson Disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a novel intervention to help people with Parkinson's disease and their caregivers make future medical decisions. The investigators hypothesize that the intervention will be feasible and acceptable.
Who is the study for?
This trial is for English-speaking Parkinson's disease patients without dementia, who can navigate websites or have assistance to do so. They must have reliable phone or internet access and not have used the intervention resources before. Those with severe vision impairment even with glasses, or a low cognitive status score are excluded.
What is being tested?
The study tests a new program designed to help Parkinson's patients and their caregivers prepare for future medical decisions. It involves early conversations about potential choices they may face as the disease progresses, aiming to ease decision-making before serious communication and cognitive issues arise.
What are the potential side effects?
Since this trial focuses on decision-making support rather than medication, traditional physical side effects are not expected. Participants may experience emotional discomfort discussing future health scenarios.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Parkinson's Disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline Advance Care Planning Engagement Survey at 2 weeks
Intervention feasibility/acceptability
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Parkinson's medical decision making support intervention groupExperimental Treatment1 Intervention
All participants will complete an online medical decision making intervention, lasting about 60 minutes, and complete pre and post surveys.
Find a Location
Who is running the clinical trial?
Purdue UniversityLead Sponsor
233 Previous Clinical Trials
71,301 Total Patients Enrolled
Jiayun XuPrincipal InvestigatorPurdue University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have already used the treatment before.You scored lower than 28 on a test to check memory and thinking skills during a phone call.You have trouble seeing even with glasses and can't read a newspaper.I have been diagnosed with Parkinson's Disease.
Research Study Groups:
This trial has the following groups:- Group 1: Parkinson's medical decision making support intervention group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.